Spirair today announced it received FDA 510(k) clearance for its SeptAlign system to treat nasal septal deviation. The SeptAlign system uses the company’s bioabsorbable implant to straighten minor cartilaginous septal deviation. The implant won FDA clearance in August 2023. Nasal septal devition is one of the most common causes of nasal airway obstruction, making breathing […]
